丹麦新发2型糖尿病无心梗患者心脏风险与死亡率全国趋势
丹麦全国队列研究纳入1996-2011年新发2型糖尿病无心梗患者209,311例,按年龄性别匹配一般人群对照。7年内心梗风险从6.9%降至2.8%,心脏死亡从7.1%降至1.6%,全因死亡从28.9%降至16.8%,风险下降与预防性心血管药物使用增加同步。
要点
- 新发2型糖尿病无心梗患者7年心梗风险从6.9%降至2.8%。
- 7年心脏死亡风险从7.1%降至1.6%,全因死亡从28.9%降至16.8%。
- 风险下降与心血管药物(尤其他汀)使用增加同步。
核心结论
- 1996至2011年丹麦新发2型糖尿病无心梗患者心脏风险与死亡率大幅下降,与预防性心血管药物使用增加同步。
研究设计与样本
- 基于全国健康登记的人口队列研究,纳入1996-2011年新发2型糖尿病无心梗患者209,311例,并按年龄性别匹配最多5倍一般人群对照,随访7年。
主要发现
- 7年心梗风险从6.9%降至2.8%(aHR 0.39,95%CI 0.37-0.42)。
- 7年心脏死亡风险从7.1%降至1.6%(aHR 0.23,95%CI 0.21-0.24)。
- 7年全因死亡风险从28.9%降至16.8%(aHR 0.68,95%CI 0.66-0.69)。
- 与一般人群相比,7年风险差:心梗从3.3%降至0.8%,心脏死亡从2.7%降至0.5%,全因死亡从10.6%降至6.0%。
关键数值与推荐
- 诊断糖尿病±1年内使用心血管药物增加,他汀使用者从1996-1999年的5%升至2008-2011年的60%。
临床怎么用
- 对新发2型糖尿病无心梗患者,应重视预防性心血管药物(尤其他汀)的使用以降低心脏风险和死亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Trends in cardiac risk and death have not been examined in patients with incident type 2 diabetes and no prior cardiovascular disease. Therefore, we aimed to examine trends in cardiac risk and death in relation to the use of prophylactic cardiovascular medications in patients with incident type 2 diabetes without prior cardiovascular disease. RESEARCH DESIGN AND METHODS: In this population-based cohort study, we included patients with incident type 2 diabetes between 1996 and 2011 through national health registries. Each patient was matched by age and sex with up to five individuals without diabetes from the general population. All individuals were followed for 7 years. RESULTS: We identified 209,311 patients with incident diabetes. From 1996-1999 to 2008-2011, the 7-year risk of myocardial infarction decreased from 6.9 to 2.8% (adjusted hazard ratio [aHR] 0.39 [95% CI 0.37-0.42]), cardiac death from 7.1 to 1.6% (aHR 0.23 [95% CI 0.21-0.24]), and all-cause death from 28.9 to 16.8% (aHR 0.68 [95% CI 0.66-0.69]). Compared with the general population, 7-year risk differences decreased from 3.3 to 0.8% for myocardial infarction, from 2.7 to 0.5% for cardiac death, and from 10.6 to 6.0% for all-cause death. Use of cardiovascular medications within ±1 year of diabetes diagnosis, especially statins (5% of users in 1996-1999 vs. 60% in 2008-2011), increased during the study period. CONCLUSIONS: From 1996 to 2011, Danish patients with incident type 2 diabetes and no prior cardiovascular disease experienced major reductions in cardiac risk and mortality. The risk reductions coincided with increased use of prophylactic cardiovascular medications.
引用
- Gyldenkerne C, Knudsen JS, Olesen KKW, et al. Nationwide Trends in Cardiac Risk and Mortality in Patients With Incident Type 2 Diabetes: A Danish Cohort Study. Diabetes Care. 2021. PMID: 34380704. doi:10.2337/dc21-0383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。